Literature DB >> 10747976

Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function.

E J Seo1, H Im, J S Maeng, K E Kim, M H Yu.   

Abstract

Serine protease inhibitors (serpins) are metastable in their native state. This strain, which is released upon binding to target proteases, is essential for the inhibitory activity of serpins. To understand the structural basis of the native strain, we previously characterized stabilizing mutations of alpha(1)-antitrypsin, a prototypical inhibitory serpin, in regions such as the hydrophobic core. The present study evaluates the effects of single point mutations throughout the molecule on stability and protease inhibitory activity. We identified stabilizing mutations in most secondary structures, suggesting that the native strain is distributed throughout the molecule. Examination of the substitution patterns and the structures of the mutation sites revealed surface hydrophobic pockets as a component of the native strain in alpha(1)-antitrypsin, in addition to the previously identified unusual interactions such as side chain overpacking and cavities. Interestingly, many of the stabilizing substitutions did not affect the inhibitory activity significantly. Those that affected the activity were confined in the regions that are mobilized during the complex formation with a target enzyme. The results of our study should be useful for designing proteins with strain and for regulating the stability and functions of serpins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747976     DOI: 10.1074/jbc.M001006200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Cavities of alpha(1)-antitrypsin that play structural and functional roles.

Authors:  C Lee; J S Maeng; J P Kocher; B Lee; M H Yu
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Probing serpin conformational change using mass spectrometry and related methods.

Authors:  Yuko Tsutsui; Anindya Sarkar; Patrick L Wintrode
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.

Authors:  Lu Liu; Nicole Mushero; Lizbeth Hedstrom; Anne Gershenson
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

4.  Preventing serpin aggregation: the molecular mechanism of citrate action upon antitrypsin unfolding.

Authors:  Mary C Pearce; Craig J Morton; Susanne C Feil; Guido Hansen; Julian J Adams; Michael W Parker; Stephen P Bottomley
Journal:  Protein Sci       Date:  2008-09-09       Impact factor: 6.725

5.  Expression and Purification of Active Recombinant Human Alpha-1 Antitrypsin (AAT) from Escherichia coli.

Authors:  Beena Krishnan; Lizbeth Hedstrom; Daniel N Hebert; Lila M Gierasch; Anne Gershenson
Journal:  Methods Mol Biol       Date:  2017

Review 6.  Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques.

Authors:  Benjamin M Scott; William P Sheffield
Journal:  Protein Sci       Date:  2019-12-09       Impact factor: 6.725

7.  Effects of glycosylation on the stability and flexibility of a metastable protein: the human serpin α(1)-antitrypsin.

Authors:  Anindya Sarkar; Patrick L Wintrode
Journal:  Int J Mass Spectrom       Date:  2011-04       Impact factor: 1.986

8.  Structural factors affecting the choice between latency transition and polymerization in inhibitory serpins.

Authors:  Ji-Yeun Yi; Hana Im
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

9.  Local and global effects of a cavity filling mutation in a metastable serpin.

Authors:  Tanusree Sengupta; Yuko Tsutsui; Patrick L Wintrode
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

10.  Functional unfolding of alpha1-antitrypsin probed by hydrogen-deuterium exchange coupled with mass spectrometry.

Authors:  Je-Hyun Baek; Won Suk Yang; Cheolju Lee; Myeong-Hee Yu
Journal:  Mol Cell Proteomics       Date:  2009-01-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.